Evidence map›Paper›PMID 40676379›Full record

ArticleAdvances in therapy2025

Use of Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis in Spain and Barriers to Implementation: A Delphi Study.

Esteban Rubio, Mª José Moreno, Adela Gallego, Isabel Castrejón, Amelia Cobo, Sebastián Moyano, Marta Comellas

Abstract read
In one paragraph

Article in Advances in therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Esteban RubioHospital Universitario Virgen del Rocio, Seville, Spain.
Mª José MorenoHospital Rafael Méndez, Lorca, Spain.
Adela GallegoHospital Don Benito-Villanueva de La Serena, Don Benito, Spain.
Isabel CastrejónHospital General Universitario Gregorio Marañón, Madrid, Spain.
Amelia CoboEli Lilly and Company, Alcobendas, Spain.
Sebastián MoyanoEli Lilly and Company, Alcobendas, Spain.
Marta ComellasOutcomes'10 (a ProductLife Group Company), Castellón De La Plana, Spain. mcomellas@outcomes10.com.ORCID http://orcid.org/0000-0002-5275-9882

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study aimed to investigate the pattern of use and barriers for implementation of patient-reported outcomes measures (PROMs) in patients with rheumatoid arthritis (RA) in Spain.

methodsTwo-round Delphi study targeted at rheumatologists attending a PROMs training program and guided by a Scientific Committee composed of four expert rheumatologists was conducted. The survey assessed the current use, appropriateness, and feasibility of 7 PROMs proposed by the International Consortium for Health Outcomes Measurements (ICHOM). Barriers to implement PROMs in routine care were also explored. A 7-point Likert scale was used ranging from 1 (strongly disagree) to 7 (strongly agree). Consensus was established when > 75% reached agreement (rated 6-7 = agreement, or 1-2 = disagreement).

resultsA total of 39 rheumatologists of 120 (32%) participated {61.5% women; mean age 50.3 [standard deviation (SD) 11.0] years; mean 18.1 (9.6) years of experience; 23.1% running a RA clinic}. Although 82.1% of rheumatologists agreed on involving patients in shared decision-making (SDM), only 56.4% adopted SDM strategies in treatment decisions. A higher percentage (79.4%) agreed on the importance of incorporating PROMs, but only 28.2% recognized to use them in routine care, being the most frequently used pain on a visual analogue scale (VAS) (89.8%), the Health Assessment Questionnaire (HAQ) (71.7%), and a VAS-fatigue (66.7%). The remaining proposed PROMs by ICHOM did not reach a consensus on either appropriateness or feasibility. The main barriers found included lack of time in consultation (84.6%) and the unavailability of PROMs platforms incorporated in the electronic medical records (87.9%).

conclusionSpanish rheumatologists consider PROMs useful to guide SDM in routine care being the most frequently used pain, fatigue, and physical function. However, other domains proposed by ICHOM as health-related quality of life (HRQoL) or work/school productivity are not commonly used. Promoting the use of PROMs strategies, including optimizing consultation time and incorporating PROMs into electronic medical records, is necessary.

Indexed as

Arthritis, RheumatoidPatient Reported Outcome MeasuresAdultDecision Making, SharedDelphi TechniqueFemaleHumansMaleMiddle AgedPatient ParticipationQuality of LifeRheumatologistsSpainDelphiPatient-reported outcomes measuresPROMsRheumatoid arthritisShared decision-making

Identifiers

PMID40676379
PMCPMC12474726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.